2001
DOI: 10.1006/bbrc.2001.5524
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and Preliminary Biological Assessment of AADGAPLIRFamide and SVPGVLRFamide from Caenorhabditis elegans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0
1

Year Published

2004
2004
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 26 publications
1
23
0
1
Order By: Relevance
“…We could not further investigate the extent to which the differentiation of the VD MNs was affected in alr-1 mutants, owing to the lack of additional VD-or DD-specific markers. The flp-13 gene is predicted to encode at least six FMRFamiderelated neuropeptides (Li et al, 1999), two of which have been biochemically isolated from C. elegans (Li et al, 1999;Marks et al, 2001). Peptides encoded by flp-13 have been shown to cause a dramatic inhibition of locomotory behavior and paralysis when injected into Ascaris suum, and inhibit pharyngeal activity in C. elegans (Marks et al, 2001;Rogers et al, 2001), suggesting that these neuropeptides may act to modulate the inhibitory functions of GABA at the neuromuscular junction.…”
Section: Discussionmentioning
confidence: 99%
“…We could not further investigate the extent to which the differentiation of the VD MNs was affected in alr-1 mutants, owing to the lack of additional VD-or DD-specific markers. The flp-13 gene is predicted to encode at least six FMRFamiderelated neuropeptides (Li et al, 1999), two of which have been biochemically isolated from C. elegans (Li et al, 1999;Marks et al, 2001). Peptides encoded by flp-13 have been shown to cause a dramatic inhibition of locomotory behavior and paralysis when injected into Ascaris suum, and inhibit pharyngeal activity in C. elegans (Marks et al, 2001;Rogers et al, 2001), suggesting that these neuropeptides may act to modulate the inhibitory functions of GABA at the neuromuscular junction.…”
Section: Discussionmentioning
confidence: 99%
“…3,[26][27][28] Recently, SYFDEKKSVPGVLRF-NH 2 was isolated 3,27 and EMPGVLRF-NH 2 was both predicted and isolated 3,27 ; neither was included in the current study. When we tested KSVPGVLRF-NH 2 (a predicted sequence 25 ) and SVPGVLRF-NH 2 (the isolated peptide [26][27][28] ), both peptides were equally potent to activate FLP-18R1b but SVPGVLRF-NH 2 was two fold more potent at the FLP-18R1a receptor (Table I). It is interesting to note that the shorter peptides were more potent than longer peptides and that the most potent was not a C. elegans but an A. suum peptide, AVPGVLRF-NH 2 (EC 50 7.6-13.1 nM).…”
Section: Elegans Gpcr Y58g8a4 Is a Flp-18 Receptor 345mentioning
confidence: 99%
“…Many neuropeptides and neuropeptide receptors are known to influence muscle and neuronal activity and ultimately locomotion in C. elegans and other nematodes (Marks et al 2001;Rogers et al 2001;Keating et al 2003;Husson et al 2007). It is possible that one or more neuromodulators required to regulate locomotion are released from neuronal DCVs in wild-type animals but are not transported properly through the neuronal secretory pathway in unc-73 RhoGEF-2 or rab-2 mutants and not properly released from unc-31 mutant neurons.…”
Section: Unc-73 Rhogef-2 Isoforms and Neuromodulatory Protein Signalingmentioning
confidence: 99%